LifeStance Health Group, Inc. Cash and Restricted Cash
LifeStance Health Group, Inc. (LFST) had Cash and Restricted Cash of $225.94 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $225.94M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $194.80M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $248.64M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $203.90M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $225.94M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $194.80M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $248.64M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $203.90M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $188.93M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $134.34M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $154.57M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $102.61M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $86.97M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $49.45M 10-Q · filed 2025-05-07 |
| 2023-12-31 | $78.82M 10-K · filed 2026-02-25 |
| 2023-09-30 | $42.60M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $79.61M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $68.29M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $108.62M 10-K · filed 2026-02-25 |
| 2022-09-30 | $90.34M 10-Q · filed 2023-11-08 |
| 2022-06-30 | $96.69M 10-Q · filed 2023-08-09 |
| 2022-03-31 | $113.99M 10-Q · filed 2023-05-10 |
| 2021-12-31 | $148.03M 10-K · filed 2025-02-27 |
| 2021-09-30 | $212.12M 10-Q · filed 2022-11-09 |
| 2021-06-30 | $276.19M 10-Q · filed 2022-08-10 |
| 2021-03-31 | $39.49M 10-Q · filed 2022-05-11 |
| 2020-12-31 | $18.83M 10-K · filed 2024-02-28 |
| 2020-09-30 | $25.07M 10-Q · filed 2021-11-10 |
| 2020-06-30 | $13.80M 10-Q · filed 2021-08-12 |
| 2020-05-14 | $27.22M 10-K · filed 2023-03-09 |
| 2020-04-12 | $0.00 10-K · filed 2023-03-09 |
| 2019-12-31 | $3.48M 10-K · filed 2023-03-09 |
| 2018-12-31 | $11.35M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |